Technical Analysis for XXII - 22nd Century Group, Inc.

Grade Last Price % Change Price Change
grade F 1.9 0.53% 0.01
XXII closed up 0.53 percent on Thursday, March 21, 2019, on 42 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical XXII trend table...

Date Alert Name Type % Chg
Mar 21 Narrow Range Bar Range Contraction 0.00%
Mar 21 Doji - Bullish? Reversal 0.00%
Mar 21 Wide Bands Range Expansion 0.00%
Mar 20 Narrow Range Bar Range Contraction 0.53%
Mar 20 NR7 Range Contraction 0.53%
Mar 20 Wide Bands Range Expansion 0.53%
Mar 19 Doji - Bullish? Reversal -2.06%
Mar 19 Outside Day Range Expansion -2.06%
Mar 19 Wide Bands Range Expansion -2.06%
Mar 18 Wide Bands Range Expansion -1.55%

Older signals for XXII ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
22nd Century Group, Inc., a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. It develops smoking cessation products for smokers who are unable or unwilling to quit smoking; and modified risk tobacco products that reduce exposure to certain tobacco smoke toxins compared to conventional cigarettes. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy; RED SUN and MAGIC regular and menthol cigarettes; and SPECTRUM government research cigarettes. It is also developing modified risk cigarettes, such as BRAND A, which has approximately 95% less nicotine than tobacco in cigarettes; and BRAND B cigarettes' with smoke that contains the lowest amount of tar per milligram of nicotine. 22nd Century Group, Inc. was founded in 1998 and is based in Clarence, New York.
Biotechnology Genetic Engineering Psychoactive Drugs Tobacco Cigarette Smoking Cessation Nicotine Smoking Tobacco Smoking
Is XXII a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.29
52 Week Low 1.58
Average Volume 1,990,762
200-Day Moving Average 2.5099
50-Day Moving Average 2.2511
20-Day Moving Average 2.088
10-Day Moving Average 1.947
Average True Range 0.1582
ADX 20.83
+DI 17.2216
-DI 24.3551
Chandelier Exit (Long, 3 ATRs ) 2.1154
Chandelier Exit (Short, 3 ATRs ) 2.0546
Upper Bollinger Band 2.593
Lower Bollinger Band 1.583
Percent B (%b) 0.31
BandWidth 48.371648
MACD Line -0.1183
MACD Signal Line -0.113
MACD Histogram -0.0053
Fundamentals Value
Market Cap 195.24 Million
Num Shares 103 Million
EPS -0.14
Price-to-Earnings (P/E) Ratio -13.57
Price-to-Sales 20.78
Price-to-Book 9.88
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.99
Resistance 3 (R3) 1.99 1.97 1.98
Resistance 2 (R2) 1.97 1.94 1.97 1.97
Resistance 1 (R1) 1.93 1.93 1.93 1.93 1.96
Pivot Point 1.91 1.91 1.91 1.91 1.91
Support 1 (S1) 1.87 1.88 1.87 1.87 1.84
Support 2 (S2) 1.85 1.87 1.85 1.83
Support 3 (S3) 1.81 1.85 1.83
Support 4 (S4) 1.81